Dominick Conde analyzes the Supreme Court’s January 20th, 2015 decision in Teva Pharmaceuticals v. Sandoz, which overturned the Federal Circuit’s de novo standard of review for district court claim constructions, and its implications on future patent litigations.
March 2015 | Intellectual Property Today
Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc.: Where Does Claim Construction Go From Here?
1 min
Related Services
Related Insights
Drafting Considerations for Transferring Your Technology Contract
Drafting Considerations for Transferring Your Technology Contract
April 09, 2024
4min
Top Ten Current Key Copyright Issues and Pitfalls Affecting Nonprofits
Top Ten Current Key Copyright Issues and Pitfalls Affecting Nonprofits
April 01, 2024
9min
Copyright Counseling and Protection
Copyright Counseling and Protection
March 26, 2024
22min
Events
AI in Pharma: Transforming Life Sciences IP and Reshaping the Hatch-Waxman Litigation Landscape
AI in Pharma: Transforming Life Sciences IP and Reshaping the Hatch-Waxman Litigation Landscape
April 25 - 26, 2024 New York, NY - American Conference Institute
Michael Joblove and Nina Greene to Speak at IFA Legal Symposium
Michael Joblove and Nina Greene to Speak at IFA Legal Symposium
May 05 - 07, 2024 Washington, DC
Patent Damages: What is Really at Stake?
Patent Damages: What is Really at Stake?
May 14, 2024 Ashburn, VI - IPWatchdog
Recent News
Variety Spotlights Three Venable Attorneys in Its 2024 Legal Impact Report
Variety Spotlights Three Venable Attorneys in Its 2024 Legal Impact Report
April 17, 2024
1min
Venable Ranks Among American Lawyer Magazine’s Top 100 Firms
Venable Ranks Among American Lawyer Magazine’s Top 100 Firms
April 17, 2024
2min
Corporate Counsel Quotes Kevin Shepherd on the Corporate Transparency Act Reporting Requirements
Corporate Counsel Quotes Kevin Shepherd on the Corporate Transparency Act Reporting Requirements
April 16, 2024
2min